ERBB2 and breast carcinoma: In our study, significant distribution differences of ER, PR, and HER2 expression were found between the low-AR group and the high-AR group, and the p-values were <0.001, <0.001, and 0.015, respectively, which contrasted to previous research and indicated interaction of protein expression might exist among those receptors in breast cancer.